Nature's Sunshine(US:NATR)2025-05-06 20:16Financial Performance - Net sales for Q1 2025 were $113.2 million, a 2.0% increase compared to $111.0 million in Q1 2024[6] - Operating income increased by 33.5% from $4.6 million in Q1 2024 to $6.2 million in Q1 2025[6] - Net income attributable to common shareholders increased by 104.5% from $2.3 million in Q1 2024 to $4.7 million in Q1 2025[6] - Adjusted EBITDA increased by 20.0% from $9.2 million in Q1 2024 to $11.0 million in Q1 2025[6] - Diluted EPS increased by 108.6% from $0.12 in Q1 2024 to $0.25 in Q1 2025[6] Balance Sheet and Cash Flow - Cash and cash equivalents totaled $86.5 million as of March 31, 2025[9, 10] - The company has zero debt as of March 31, 2025[9, 10] - Cash from operations totaled $2.6 million for Q1 2025[9, 10] - Free cash flow totaled $1.5 million for Q1 2025[9, 10] Sales by Operating Segment - Asia net sales increased by 5.3% from $46.22 million in Q1 2024 to $48.653 million in Q1 2025[11] - Europe net sales increased by 8.2% from $22.296 million in Q1 2024 to $24.114 million in Q1 2025[11] - North America net sales decreased by 4.1% from $36.525 million in Q1 2024 to $35.018 million in Q1 2025[11]